{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "84126-310",
      "generic_name": "Dextromethorphan HBr, Guaifenesin",
      "labeler_name": "The Procter & Gamble Manufacturing Company",
      "brand_name": "Vicks DayQuil Kids FREE OF ARTIFICIAL DYES and SUGAR COLD and COUGH plus MUCUS",
      "brand_name_suffix": "FREE OF ARTIFICIAL DYES and SUGAR COLD and COUGH plus MUCUS",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "10 mg/15mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "200 mg/15mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "84126-310-06",
          "description": "177 mL in 1 BOTTLE, PLASTIC (84126-310-06)",
          "marketing_start_date": "20240625",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "LIQUID",
      "spl_id": "5d1a1ae4-8a05-cd41-e063-6394a90aee2f",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20240625",
      "product_id": "84126-310_5d1a1ae4-8a05-cd41-e063-6394a90aee2f",
      "application_number": "M012",
      "brand_name_base": "Vicks DayQuil Kids",
      "pharm_class": [
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}